Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Apr-24 10:00 PM View:  | Altamont Pharmaceutical Hol... 10% Owner | Galera Therapeutics, Inc. (GRTX) | 28-Mar-24 | Sale | 693,076 | $0.15 | $101,120.00 | (39%) 1.77M to 1.08M | |
| 01-Apr-24 10:00 PM View: | Altamont Pharmaceutical Hol... 10% Owner | Galera Therapeutics, Inc. (GRTX) | 27-Mar-24 | Sale | 306,924 | $0.17 | $52,146.40 | (15%) 2.08M to 1.77M | |
| 01-Apr-24 10:00 PM View: | Altamont Pharmaceutical Hol... 10% Owner | Galera Therapeutics, Inc. (GRTX) | 26-Mar-24 | Sale | 2,000,000 | $0.20 | $393,000.00 | (49%) 4.08M to 2.08M | |
| 01-Apr-24 10:00 PM View: | Altamont Pharmaceutical Hol... 10% Owner | Galera Therapeutics, Inc. (GRTX) | 25-Mar-24 | Sale | 780,000 | $0.22 | $170,742.00 | (16%) 4.86M to 4.08M | |
| 01-Apr-24 10:00 PM View: | Altamont Pharmaceutical Hol... 10% Owner | Galera Therapeutics, Inc. (GRTX) | 22-Mar-24 | Sale | 20,000 | $0.23 | $4,600.00 | (< 1%) 4.88M to 4.86M | |
| 26-Feb-24 4:06 PM View: | Schneid Yair 10% Owner | Galera Therapeutics, Inc. (GRTX) | 08-Feb-24 | Purchase | 150,000 | $0.17 | $25,650.00 | 2% 7.89M to 8.04M | |
| 26-Feb-24 4:06 PM View: | Schneid Yair 10% Owner | Galera Therapeutics, Inc. (GRTX) | 07-Feb-24 | Purchase | 175,000 | $0.17 | $30,185.00 | 2% 7.72M to 7.89M | |
| 26-Feb-24 4:06 PM View: | Schneid Yair 10% Owner | Galera Therapeutics, Inc. (GRTX) | 06-Feb-24 | Purchase | 25,000 | $0.20 | $5,025.00 | < 1% 7.69M to 7.72M | |
| 26-Feb-24 4:06 PM View: | Schneid Yair 10% Owner | Galera Therapeutics, Inc. (GRTX) | 05-Feb-24 | Purchase | 97,402 | $0.18 | $17,922.00 | 1% 7.6M to 7.69M | |
| 26-Feb-24 4:06 PM View: | Schneid Yair 10% Owner | Galera Therapeutics, Inc. (GRTX) | 30-Jan-24 | Purchase | 335,000 | $0.18 | $60,635.00 | 5% 7.26M to 7.6M | |
| 26-Feb-24 4:06 PM View: | Schneid Yair 10% Owner | Galera Therapeutics, Inc. (GRTX) | 29-Jan-24 | Private Purchase | 150,000 | $0.18 | $27,000.00 | 2% 7.11M to 7.26M | |
| 01-Apr-24 10:00 PM View: | Altamont Pharmaceutical Hol... 10% Owner | Galera Therapeutics, Inc. (GRTX) | 11-Jan-24 | Sale | 400,000 | $0.23 | $90,240.00 | (8%) 5.28M to 4.88M | |
| 20-Mar-23 4:05 PM View: | Bachleda Mark Chief Commercial Officer | Galera Therapeutics, Inc. (GRTX) | 16-Mar-23 | Private Purchase | 11,000 | $2.25 | $24,717.00 | 100% 0 to 11.0K | |
| 14-Mar-23 8:30 AM View: | Degnan Chris Chief Financial Officer | Galera Therapeutics, Inc. (GRTX) | 13-Mar-23 | Private Purchase | 10,000 | $1.96 | $19,593.00 | 100% 0 to 10.0K | |
| 14-Mar-23 8:30 AM View: | Sorensen Mel President and CEO Director | Galera Therapeutics, Inc. (GRTX) | 10-Mar-23 | Private Purchase | 100,000 | $1.68 | $168,120.00 | 43% 232.04K to 332.04K | |
| 22-Nov-22 4:05 PM View: | Beardsley Robert A Chief Operating Officer | Galera Therapeutics, Inc. (GRTX) | 21-Nov-22 | Option Exercise | 10,000 | $1.07 | $10,700.00 | 10% 98.19K to 108.19K | |
| 13-Sep-22 4:10 PM View: | Beardsley Robert A Chief Operating Officer | Galera Therapeutics, Inc. (GRTX) | 12-Sep-22 | Option Exercise | 10,000 | $1.07 | $10,700.00 | 11% 88.19K to 98.19K | |
| 20-Jul-22 6:05 AM View: | Alleva Lawrence M Director | Galera Therapeutics, Inc. (GRTX) | 18-Jul-22 | Gift | 4,000 | -- | -- | (28%) 14.37K to 10.37K | |
| 20-Dec-21 6:30 PM View: | West Linda Director | Galera Therapeutics, Inc. (GRTX) | 17-Dec-21 | Market Purchase | 20,000 | $2.74 | $54,804.00 | 50% 40.0K to 60.0K | 8% |
| 20-Dec-21 6:30 PM View: | Beardsley Robert A Chief Operating Officer | Galera Therapeutics, Inc. (GRTX) | 17-Dec-21 | Option Exercise | 20,000 | $1.07 | $21,400.00 | 29% 68.19K to 88.19K | |
| 03-Sep-21 10:00 PM View: | Holmlud Jon T Chief Medical Officer | Galera Therapeutics, Inc. (GRTX) | 01-Sep-21 | Option Exercise | 47,756 | $2.43 | $116,047.00 | 100% 0 to 47.76K | |
| 03-Sep-21 10:00 PM View: | Holmlud Jon T Chief Medical Officer | Galera Therapeutics, Inc. (GRTX) | 01-Sep-21 | Market Option Sale (Planned) | 47,756 | $8.47 | $404,498.00 | (100%) 47.76K to 0 | |
| 17-Jun-21 6:41 PM View: | West Linda Director | Galera Therapeutics, Inc. (GRTX) | 15-Jun-21 | Market Purchase | 10,000 | $9.13 | $91,300.00 | 33% 30.0K to 40.0K | (3%) |
| 04-Jun-21 8:13 PM View: | West Linda Director | Galera Therapeutics, Inc. (GRTX) | 02-Jun-21 | Market Purchase | 10,000 | $8.65 | $86,511.00 | 50% 20.0K to 30.0K | 4% |
| 02-Jun-21 5:35 PM View: | West Linda Director | Galera Therapeutics, Inc. (GRTX) | 01-Jun-21 | Market Purchase | 10,000 | $8.64 | $86,381.00 | 100% 10.0K to 20.0K | (< 1%) |
| 03-Jun-21 5:22 PM View: | Alleva Lawrence M Director | Galera Therapeutics, Inc. (GRTX) | 01-Jun-21 | Market Purchase | 4,045 | $8.59 | $34,741.30 | 64% 6.33K to 10.37K | (< 1%) |
| 02-Jun-21 5:35 PM View: | West Linda Director | Galera Therapeutics, Inc. (GRTX) | 28-May-21 | Market Purchase | 10,000 | $8.64 | $86,410.00 | 100% 0 to 10.0K | (< 1%) |
| 30-Mar-21 4:42 PM View: | Sorensen Mel President and CEO Director | Galera Therapeutics, Inc. (GRTX) | 26-Mar-21 | Option Exercise | 217,015 | $1.09 | $235,492.00 | 1444% 15.03K to 232.04K | |
| 19-Feb-21 5:20 PM View: | Novo A/s 10% Owner | Galera Therapeutics, Inc. (GRTX) | 18-Feb-21 | Market Sale | 500,000 | $10.58 | $5,290,000.00 | (17%) 2.96M to 2.46M | (11%) |
| 17-Nov-20 4:06 PM View: | Alleva Lawrence M Director | Galera Therapeutics, Inc. (GRTX) | 13-Nov-20 | Purchase | 2,325 | $10.22 | $23,771.30 | 58% 4.0K to 6.33K | |
| 16-Nov-20 7:46 PM View: | Sussman Joel F. Chief Accounting Officer | Galera Therapeutics, Inc. (GRTX) | 13-Nov-20 | Option Sale | 10,000 | $10.32 | $103,197.00 | (100%) 10.0K to 0 | |
| 16-Nov-20 7:46 PM View: | Sussman Joel F. Chief Accounting Officer | Galera Therapeutics, Inc. (GRTX) | 13-Nov-20 | Option Exercise | 10,000 | $1.46 | $14,551.90 | 100% 0 to 10.0K | |
| 16-Nov-20 7:46 PM View: | Sussman Joel F. Chief Accounting Officer | Galera Therapeutics, Inc. (GRTX) | 12-Nov-20 | Option Exercise | 10,000 | $1.07 | $10,700.00 | 100% 0 to 10.0K | |
| 16-Nov-20 7:46 PM View: | Sussman Joel F. Chief Accounting Officer | Galera Therapeutics, Inc. (GRTX) | 12-Nov-20 | Option Sale | 10,000 | $10.06 | $100,627.00 | (100%) 10.0K to 0 | |
| 28-Oct-20 5:56 PM View: | Holmlud Jon T Chief Medical Officer | Galera Therapeutics, Inc. (GRTX) | 26-Oct-20 | Planned Option Sale | 2,244 | $15.00 | $33,660.00 | (100%) 2.24K to 0 | |
| 28-Oct-20 5:56 PM View: | Holmlud Jon T Chief Medical Officer | Galera Therapeutics, Inc. (GRTX) | 26-Oct-20 | Option Exercise | 2,244 | $2.43 | $5,452.92 | 100% 0 to 2.24K | |
| 19-Oct-20 4:34 PM View: | Novo A/s 10% Owner | Galera Therapeutics, Inc. (GRTX) | 15-Oct-20 | Sale | 450,000 | $11.00 | $4,950,000.00 | (13%) 3.41M to 2.96M | |
| 07-Oct-20 5:01 PM View: | Holmlud Jon T Chief Medical Officer | Galera Therapeutics, Inc. (GRTX) | 06-Oct-20 | Planned Option Sale | 10,536 | $12.00 | $126,432.00 | (100%) 10.54K to 0 | |
| 07-Oct-20 5:01 PM View: | Holmlud Jon T Chief Medical Officer | Galera Therapeutics, Inc. (GRTX) | 06-Oct-20 | Option Exercise | 10,536 | $1.11 | $11,667.80 | 100% 0 to 10.54K | |
| 07-Oct-20 5:01 PM View: | Holmlud Jon T Chief Medical Officer | Galera Therapeutics, Inc. (GRTX) | 05-Oct-20 | Option Exercise | 100 | $1.07 | $107.00 | 100% 0 to 100 | |
| 07-Oct-20 5:01 PM View: | Holmlud Jon T Chief Medical Officer | Galera Therapeutics, Inc. (GRTX) | 05-Oct-20 | Planned Option Sale | 100 | $12.00 | $1,200.00 | (100%) 100 to 0 | |
| 22-Jun-20 4:52 PM View: | Novartis Bioventures Ltd | Galera Therapeutics, Inc. (GRTX) | 19-Jun-20 | Sale | 1,001,310 | $8.25 | $8,260,820.00 | (29%) 3.47M to 2.47M | |
| 22-Jun-20 4:52 PM View: | Novartis Bioventures Ltd | Galera Therapeutics, Inc. (GRTX) | 18-Jun-20 | Sale | 900 | $9.04 | $8,136.00 | (< 1%) 3.47M to 3.47M | |
| 17-Jun-20 5:47 PM View: | Novartis Bioventures Ltd 10% Owner | Galera Therapeutics, Inc. (GRTX) | 17-Jun-20 | Sale | 4,622 | $9.27 | $42,845.90 | (< 1%) 3.47M to 3.47M | |
| 17-Jun-20 5:47 PM View: | Novartis Bioventures Ltd 10% Owner | Galera Therapeutics, Inc. (GRTX) | 16-Jun-20 | Sale | 8,600 | $9.30 | $79,980.00 | (< 1%) 3.48M to 3.47M | |
| 17-Jun-20 5:47 PM View: | Novartis Bioventures Ltd 10% Owner | Galera Therapeutics, Inc. (GRTX) | 15-Jun-20 | Sale | 6,164 | $9.05 | $55,784.20 | (< 1%) 3.49M to 3.48M | |
| 12-Jun-20 6:33 PM View: | Novartis Bioventures Ltd 10% Owner | Galera Therapeutics, Inc. (GRTX) | 12-Jun-20 | Sale | 1,500 | $9.19 | $13,785.00 | (< 1%) 3.49M to 3.49M | |
| 12-Jun-20 6:33 PM View: | Novartis Bioventures Ltd 10% Owner | Galera Therapeutics, Inc. (GRTX) | 11-Jun-20 | Sale | 7,200 | $9.21 | $66,312.00 | (< 1%) 3.5M to 3.49M | |
| 12-Jun-20 6:33 PM View: | Novartis Bioventures Ltd 10% Owner | Galera Therapeutics, Inc. (GRTX) | 10-Jun-20 | Sale | 8,532 | $9.46 | $80,712.70 | (< 1%) 3.51M to 3.5M | |
| 09-Jun-20 8:02 PM View: | Novartis Bioventures Ltd 10% Owner | Galera Therapeutics, Inc. (GRTX) | 09-Jun-20 | Sale | 7,000 | $9.38 | $65,660.00 | (< 1%) 3.51M to 3.51M |
